Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs

This is a multi-center, Phase 1/2/3, single-arm, open-label, single-dose treatment clinical study to evaluate the safety, tolerability and efficacy of BBM-H803 injection in severe Hemophilia A subjects. BBM-H803 is an adeno-associated viral (AAV) vector derived from recombinant DNA techniques to contain an expression cassette of the human factor VIII transgene and raises circulating levels of endogenous FVIII.

Participants needed: 55
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: Shanghai Xinzhi BioMed Co., Ltd.Updated: Mar 17, 2026Locations: 10
Eligibility criteria

Subjects voluntarily sign informed consent form; [+7]

Being positive for hepatitis B surface antigen (HBsAg) or hepatitis B virus-DNA... [+11]

Read more
Status: Recruiting

A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease

The purpose of the study is to evaluate the safety and tolerability of BBM-P002 for stereotactic injection to treat participants with idiopathic Parkinson's Disease (PD) during the dose-limiting toxicity (DLT) observation period.

Participants needed: 18
Trial details
Phase: Phase 1Age: 40-70Biological sex: AllType: InterventionalSponsor: Shanghai Xinzhi BioMed Co., Ltd.Updated: Jan 28, 2026Locations: 1
Eligibility criteria

Participants with a diagnosis of Parkinson's disease for ≥ 5 years. [+9]

Atypical or secondary Parkinsonism [+19]

Read more